Skip to main content
SpringerLink
Log in

“Autopsy Eye”: The Eye in Systemic Disease

  • Chapter
  • First Online:
Lee's Ophthalmic Histopathology

  • 822 Accesses

Abstract

Autopsy is often the only way of obtaining material for histological study from conditions such as age-related macular degeneration or various retinopathies. It is also a valuable source that allows the study of the eye in various systemic or multisystem diseases. If systemic hypertension is uncontrolled this leads to retinal vascular ischaemia usually by way of microinfarcts. Fibrinoid necrosis may be seen in choroidal vessels. Sclerokeratitis may be seen in rheumatoid arthritis, various vasculitides and other autoimmune diseases such as systemic lupus erythematosus. Deposits of leukaemia and lymphoma are usually seen in the choroid and haemorrhages may also occur. Retinitis pigmentosa is frequently only studied at the late stage where there is bone spicule pigmentation with sparing of the macular region. A common feature in syndromic retinal degeneration appears to be abnormalities in the cilia. Metabolic deficiencies may also affect the eye. These include lysosomal storage disorders, peroxisomal storage disorders, lipofuscinosis and aminoacidopathies. Mitochondrial disorders also occur. The effects of demyelinating disease such as multiple sclerosis may also be seen in the eye.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Szucs G, Szekanecz Z, Aszalos Z, Gesztelyi R, Zsuga J, Szodoray P, et al. A wide spectrum of ocular manifestations signify patients with systemic sclerosis. Ocul Immunol Inflamm. 2019;2:1–9.

    Google Scholar 

  2. Kreps EO, Carton C, Cutolo M, Cutolo CA, Vanhaecke A, Leroy BP, et al. Ocular involvement in systemic sclerosis: a systematic literature review, it’s not all scleroderma that meets the eye. Semin Arthritis Rheum. 2019;49:119–25.

    Article  PubMed  Google Scholar 

  3. Preble JM, Silpa-archa S, Foster CS. Ocular involvement in systemic lupus erythematosus. Curr Opin Ophthalmol. 2015;26:540–5.

    Article  PubMed  Google Scholar 

  4. Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus. A review of the literature. Autoimmune Dis. 2012;2012:290898.

    PubMed  PubMed Central  Google Scholar 

  5. Santoro FA, Huang J. Ocular involvement in cutaneous connective tissue disease. Clin Dermatol. 2016;34:138–45.

    Article  PubMed  Google Scholar 

  6. Choudhary MM, Hajj-Ali RA, Lowder CY. Gender and ocular manifestations of connective tissue disease and systemic vasculitides. J Ophthalmol. 2014;2014:403042.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Nag TC, Wadhwa S. Vascular changes of the retina and choroid in systemic lupus erythematosus: pathology and pathogenesis. Curr Neurovasc Res. 2006;3:159–68.

    Article  PubMed  Google Scholar 

  8. Ellison D, Gatter K, Heryet A, Esiri M. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol. 1993;46:37–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lyons HS, Quick V, Sinclair AJ, Nagaraju S, Mollan SP. A new era for giant cell arteritis. Eye (Lond). 2020;34:1013–26.

    Article  CAS  Google Scholar 

  10. Hankins M, Amin S, Gonzalez A, Samy H. Combined bilateral ophthalmic artery occlusion and central retinal vein occlusion from presumed giant cell arteritis. Am J Ophthalmol Case Rep. 2018;14:28–31.

    Article  Google Scholar 

  11. Patel HR, Margo CE. Pathology of ischemic optic neuropathy. Arch Pathol Lab Med. 2017;141:162–6.

    Article  PubMed  Google Scholar 

  12. Rüegg S, Engelter S, Jeanneret C, Hetzel A, Probst A, Steck AJ. Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine (Baltimore). 2003;82:1–12.

    Article  Google Scholar 

  13. Ray-Chaudhuri N, Kiné DA, Tijani SO, Parums DV, Cartlidge N, Strong NP, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002;86(5):530–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Guevara RA, Newman NJ, Grossniklaus HE. Positive temporal artery biopsy 6 months after prednisone treatment. Arch Ophthalmol. 1998;116:1252–3.

    CAS  PubMed  Google Scholar 

  15. Kerr NM, Chew SSS, Danesh-Meyer HV. Non-arteritic anterior ischaemic optic neuropathy: a review and update. J Clin Neurosci. 2009;16:994–1000.

    Article  PubMed  Google Scholar 

  16. Van Oterendorp C, Lagrèze WA, Feltgen N. Non-arteritic anterior ischaemic optic neuropathy: pathogenesis and therapeutic approaches. Klin Monbl Augenheilkd. 2019;236:1283–91.

    PubMed  Google Scholar 

  17. Palombi K, Renard E, Levy P, Chiquet C, Deschaux CH, Romanet JP, Pépin JL. Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol. 2006;90(7):879–82. Epub 2006 Mar 23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Munteanu M, Rosca C, Stanca H. Sub-inner limiting membrane hemorrhage in a patient with Terson syndrome. Int Ophthalmol. 2019;39:461–4.

    Article  CAS  PubMed  Google Scholar 

  19. MacDonald IM, Russell L, Chan C-C. Choroideremia: new findings from ocular pathology and review of recent literature. Surv Ophthalmol. 2009;54:401–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Birnbaum FA, Meekins LC, Srinivasan A, Murchison AP. A lot of nerve. Surv Ophthalmol. 2020;65:272–7.

    Article  PubMed  Google Scholar 

  21. Mudhar HS, Sethuraman C, Khan MD, Jan SU. Intracular, pan-uveal intravascular large B-cell lymphoma associated with choroidal infarction and choroidal tri-lineage extramedullary haematopoiesis. Histopathology. 2007;51(2):275–9. Epub 2007 Jun 25.

    Article  CAS  PubMed  Google Scholar 

  22. Pilon AF, Rhee PS, Messner LV. Bilateral, persistent serous macular detachments with Waldenström’s macroglobulinemia. Optom Vis Sci. 2005;82(7):573–8.

    Article  PubMed  Google Scholar 

  23. Fung S, Selva D, Leibovitch I, Hsuan J, Crompton J. Ophthalmic manifestations of multiple myeloma. Ophthalmologica. 2005;219:43–8.

    Article  PubMed  Google Scholar 

  24. Chin KJ, Kempin S, Milman T, Finger PT. Ocular manifestations of multiple myeloma: three cases and a review of the literature. Optometry. 2011;82:224–30.

    Article  PubMed  Google Scholar 

  25. Ortiz JM, Yanoff M, Cameron JD, Schaffer D. Disseminated intravascular coagulation in infancy and in the neonate. Ocular Findings Arch Ophthalmol. 1982;100:1413–5.

    Article  CAS  PubMed  Google Scholar 

  26. Shileds CL, Hogarty MD, Kligman BE, Christain C, Ehya H, Shields JA. Langerhans cell histiocytosis of the uvea with neovascular glaucoma: diagnosis by fine-needle aspiration biopsy and management with intraocular bevacizumab and brachytherapy. J AAPOS. 2010;14:534–7.

    Article  Google Scholar 

  27. Kim IT, Lee SM. Choroidal Langerhans’ cell histiocytosis. Acta Ophthalmol Scand. 2000;78(1):97–100.

    Article  CAS  PubMed  Google Scholar 

  28. Hall NF, Gale CR, Ye S, Martyn CN. Myopia and polymorphisms in genes for matrix metalloproteinases. Invest Ophthalmol Vis Sci. 2009;50:2632–6.

    Article  PubMed  Google Scholar 

  29. Francisco BM, Slavador M, Amparo N. Oxidative stress in myopia. Oxid Med Cell Longev. 2015;2015:750637.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Vagge A, Ferro Desideri L, Nucci P, Serafino M, Giannaccare G, Traverso C. Prevention of myopia: a systematic review. Diseases. 2018;6:92.

    Article  CAS  PubMed Central  Google Scholar 

  31. Coviltir V, Burcel M, Cherecheanu AP, Ionescu C, Dascalescu D, Potop V, et al. Update on myopia risk factors and microenvironmental changes. J Ophthalmol. 2019;2019:4960852.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Cooke Bailey JN, Sobrin L, Pericak-Vance MA, Haines JL, Hammond CJ, Wiggs JL. Advances in the genomics of common eye diseases. Hum Mol Genet. 2013;22:R59–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Grossniklaus HE, Green WR. Pathologic findings in pathologic myopia. Retina. 1992;12:127–33.

    Article  CAS  PubMed  Google Scholar 

  34. Jensen OA. Bruch’s membrane in pseudoxanthoma elasticum. Histochemical, ultrastructural and x-ray microanalytical study of the membrane and angioid streak areas. Albert Von Graefes Arch Klin Exp Ophthalmol. 1977;203:311–20.

    Article  CAS  Google Scholar 

  35. Jampol LM, Acheson R, Eagle RC, Serjeant G, O’Grady R. Calcification of Bruch’s membrane in angioid streaks with homozygous sickle cell disease. Arch Ophthalmol. 1987;105:93–8.

    Article  CAS  PubMed  Google Scholar 

  36. Kennedy CJ, Rakoczy PE, Constable IJ. Lipofuscin of the retinal pigment epithelium: a review. Eye (Lond). 1995;9:763–71.

    Article  Google Scholar 

  37. Cunea A, Jeffery G. The ageing photoreceptor. Vis Neuorsci. 2007;24:151–5.

    Article  Google Scholar 

  38. Rozing MP, Durhuus JA, Nielsen MK, Subhi Y, Kirkwood TBI, Westendorp RG, et al. Age-realted macular degeneration: a two-level model hypothesis. Porg Retin Eye Res. 2020;76:100825.

    Article  Google Scholar 

  39. Blasiak J. Senescence in the pathogenesis of age-related macular degeneration. Cell Mol Life Sci. 2012;77:789–805.

    Article  CAS  Google Scholar 

  40. Crouch RK, Koutalos Y, Kono M, Schey K, Ablonczy Z. A2E and Liposfuscin. Prog Mol Biol Transl Sci. 2015;134:449–63.

    Article  PubMed  Google Scholar 

  41. Hope Ross MW, Mahon GJ, Gardiner TA, Archer DB. Ultrastructural findings in solar retinopathy. Eye. 1993;7:29–33.

    Article  PubMed  Google Scholar 

  42. Goss-Sampson MA, Kriss T, Muller DP. Retinal abnormalities in experimental vitamin E deficiency. Free Radic Biol Med. 1998;25:457–62.

    Article  CAS  PubMed  Google Scholar 

  43. Aleman TS, Garrity ST, Brucker AJ. Retinal structure in vitamin a deficiency as explored with multimodal imaging. Doc Ophthalmol. 2013;127:239–43.

    Article  PubMed  Google Scholar 

  44. Tsang SH, Sharma T. Autosomal dominant retinitis pigmentosa. Adv Exp Med Biol. 2018;1085:69–77.

    Article  PubMed  Google Scholar 

  45. Athanasiou D, Aguila M, Bellingham J, Wenwen L, McCulley C, Reeves PJ, et al. The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy. Prog Retin Eye Res. 2018;62:1–23.

    Article  CAS  PubMed  Google Scholar 

  46. Mendes HF, Van der Spuy J, Chapple JP, Cheetham ME. Mechanisma of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol Med. 2005;11:177–85.

    Article  CAS  PubMed  Google Scholar 

  47. Farkas MH, Lew DS, Sousa ME, Bujakowska K, Chatagnon J, Bhattacharya SS, et al. Mutation in pre-mRNA processing factors 3, 8 and 31 cause dysfunction of the retinal pigment epithelium. Am J Pathol. 2014;184:2641–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Diakatou M, Manes G, Bocquet B, Meunier I, Kalatzis V. Genome editing as a treatment for the most prevalent causative genes of autosomal dominant retinitis pigmentosa. Int J Mol Sci. 2019;20:2542.

    Article  CAS  PubMed Central  Google Scholar 

  49. Albarry MA, Hashmi JA, Alreheli AQ, Albalawi AM, Khan B, Ramzan K, et al. Novel homozygous loss-of-function mutations in RP1 and RP1L1 genes in retinitis pigmentosa patients. Ophthalmic Genet. 2019;40:507–13.

    Article  CAS  PubMed  Google Scholar 

  50. Farrar GJ, Carrigan M, Dockery A, Millington-Ward S, Palfi A, Chadderton N, et al. Toward an elucidation of the molecular genetics of inherited retinal degenerations. Hum Mol Genet. 2017;26:R2–R11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Nguyen X, Talib M, van Schooneveld MJ, Brinks J, ten Brink J, Florijn RJ, et al. RPGR-associated dystrophies: clinical, genetic, and histopathological features. Int J Mol Sci. 2020;21:835.

    Article  CAS  PubMed Central  Google Scholar 

  52. Salvetti AP, Nanda A, MacLaren RE. RPGR-related X-linked retinitis pigmentosa carriers with a severe “male pattern”. Ophthalmologica. 2020;20:1–8.

    CAS  Google Scholar 

  53. Lyraki R, Megaw R, Hurd T. Disease mechanisms of X-linked retinitis pigmentosa due to RP2 and RPGR mutations. Biochem Soc Trans. 2016;44:1235–44.

    Article  CAS  PubMed  Google Scholar 

  54. Maryam A, Veithi SC, Khalid RR, Alsulami AF, Torres PHM, Siddiqi AR, et al. The molecular organization of human cGMP specific phosphodiesterase 6 (PDE6): structural implications of somatic mutations in cancer and retinitis pigmentosa. Comput Struct Biotechnol J. 2019;17:378–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. El-Aziz MMA, El-Ashry MF, Barragan I, Marcos I, Borrego S, Guillermo A, et al. Molecular genetic analysis of two functional candidate genes in the autosomal recessive retinitis pigmentosa, RP25, locus. Curr Eye Res. 2005;30:1081–7.

    Article  CAS  Google Scholar 

  56. Owczarek-Lipska M, Song F, Jakšić V, Neidhart J. Compound heterozygous RPE65 mutations associated with an early onset autosomal recessive retinitis pigmentosa. J Gene Med. 2020;22:e3211.

    Article  CAS  PubMed  Google Scholar 

  57. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92–5.

    Article  CAS  PubMed  Google Scholar 

  58. Cehajic-Kapetanovic J, Xue K, de la Camara CM-F, Nanda A, Davies A, Wood LJ, et al. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa causd by mutation in RPGR. Nat Med. 2020;26:354–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. To K, Adamian N, Jakobiec FA, Berson EL. Histopathologic and immunohistochemical study of dominant cone degeneration. Am J Ophthalmol. 1998;126:140–2.

    Article  CAS  PubMed  Google Scholar 

  60. Rabb MF, Tso MOM, Fishman GA. Cone-rod dystrophy. A clinical and histopathologic report. Ophthalmology. 1986;93:1443–51.

    Article  CAS  PubMed  Google Scholar 

  61. Badano JL, Mitsuma N, Beales PL, Katsanis N. The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet. 2006;7:125–48.

    Article  CAS  PubMed  Google Scholar 

  62. Khanna H, Baehr W. Retina ciliopathies: from genes to mechanisms and treatment. Vision Res. 2012;75:1.

    Article  PubMed  Google Scholar 

  63. Bachmann-Gagescu R, Neuhauss SCF. The photoreceptor cilium and its disease. Curr Opin Genet Dev. 2019;56:22–33.

    Article  CAS  PubMed  Google Scholar 

  64. Adams NA, Awadein A, Toma HS. The retinal ciliopathies. Ophthalmic Genet. 2007;28:113–25.

    Article  CAS  PubMed  Google Scholar 

  65. Berson EL, Adamian M. Ultrastructural findings in an autopsy eye from a patient with Usher’s syndrome type II. Am J Ophthalmol. 1992;114:748–57.

    Article  CAS  PubMed  Google Scholar 

  66. Noble KG, Carr RE. Leber’s congenital amaurosis: a retrospective study of 33 cases and a histopathologic study of one case. Arch Ophthalmol. 1978;96:818–21.

    Article  CAS  PubMed  Google Scholar 

  67. Capon MR, Marshall J, Krafft JI. Sorsby’s fundus dystrophy. A light and electron microscopic study. Ophthalmology. 1989;96:1769–77.

    Article  CAS  PubMed  Google Scholar 

  68. Christensen DRG, Brown FE, Cree AJ, Ratnayaka JA, Lotery AJ. SOrsby fundus dystrophy—a review of pathology and disease mechanisms. Exp Eye Res. 2017;165:35–46.

    Article  CAS  PubMed  Google Scholar 

  69. Fecarotta S, Tarallo A, Damiano C, Minopoli N, Parenti G. Pathogenesis of mucopolysaccharidoses, an update. Int J Mol Sci. 2020;21:2515.

    Article  CAS  PubMed Central  Google Scholar 

  70. Iwamoto M, Nawa Y, Maumenee IH, Young-Ramsaran J, Matalan R, Green WR. Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV a). Graefes Arch Clin Exp Ophthalmol. 1990;228:342–9.

    Article  CAS  PubMed  Google Scholar 

  71. Sánchez LR, Oatts JT, Duncan JL, Packman S, Moore AT. Ocular findings in a patient with fucosidosis. Am J Ophthalmol Case Rep. 2016;4:83–6.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Hoshino M, O’Brien TP, McDonnell JM, de la Cruz Z, Green WR. Fucosidosis: ultrastructural study of the eye in an adult. Graefes Arch Clin Exp Ophthalmol. 1989;227:162–71.

    Article  CAS  PubMed  Google Scholar 

  73. Werdich XQ, Place EM, Pierce EA. Systemic diseases associated with retinal dystrophies. Semin Ophthalmol. 2014;29(5–6):319–28.

    Article  PubMed  Google Scholar 

  74. Bozorg S, Ramirez-Montelaegre D, Chung M, Pearce DA. Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye. Surv Ophthalmol. 2009;54:463–71.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Bensaoula T, Shibuya H, Katz ML, Smith JE, Johnson GS, John SK, et al. Histopathology and immunocytochemical analysis of the retina and ocular tissues in batten disease. Ophthalmology. 2000;107:1746–53.

    Article  CAS  PubMed  Google Scholar 

  76. Bateman JB, Philippart M. Ocular features of the Hagberg-Santavuori syndrome. Am J Ophthalmol. 1986;102:262–71.

    Article  CAS  PubMed  Google Scholar 

  77. Traboulsi EI, Green WR, Luckenbach MW, de la Cruz ZC. Neuronal ceroid lipofuscinosis. Ocular histopathologic and electron microscopic studies in the late infantile, juvenile and adult forms. Graefes Arch Clin Exp Ophthalmol. 1987;225:391–402.

    Article  CAS  PubMed  Google Scholar 

  78. Elmonem MA, Veys KR, Soliman NA, van Dyck M, van den Heuvel LP, Levtchenko E. Cystinosis: a review. Orphanet J Rare Dis. 2016;11:47.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Mungan N, Nischal KK, Heon E, MacKeen L, Balfe JW, Levin AV. Ultrasound biomicroscopy of the eye in cystinosis. Arch Ophthalmol. 2000;118:1329–33.

    Article  CAS  PubMed  Google Scholar 

  80. Kocabora MS, Ozbilen KT, Altunsoy M, Ahishali B, Taskapili M. Clincopathological features of ocular cystinosis. Clin Experiment Ophthalmol. 2008;36:778–81.

    Article  PubMed  Google Scholar 

  81. Folz SJ, Trobe JD. The peroxisome and the eye. Surv Ophthalmol. 1991;35:353–68.

    Article  CAS  PubMed  Google Scholar 

  82. Glasgow BJ, Brown HH, Hannah JB, Foos RY. Ocular pathologic findings in neonatal adrenoleukodystrophy. Ophthalmology. 1987;94:1054–60.

    Article  CAS  PubMed  Google Scholar 

  83. Van den Brink DM, Brites P, Haasjes J, Wierzbicki AS, Mitchell J, Lambert-Hamill M, et al. Identification of PEX7 as the second gene involved in Refsum disease. Am J Hum Genet. 2003;72:471–7.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Toussaint D, Danis P. An ocular pathological study of Refsum’s syndrome. Am J Ophthalmol. 1971;72:342–7.

    Article  CAS  PubMed  Google Scholar 

  85. Flament-Durand J, Noel P, Rutsaert J, Toussaint D, Malmendier C, Lyon G. A case of Refsum’s disease: clinical, pathological, ultrastructural and biochemical study. Pathol Eur. 1971;6:172–91.

    CAS  PubMed  Google Scholar 

  86. Birtel J, Herrmann P, Garrelfs SF, Dulz S, Atiskova Y, Diederen RM, et al. The ocular phenotype in primary hyperoxaluria type 1. Am J Ophthalmol. 2019;206:184–91.

    Article  PubMed  Google Scholar 

  87. Theodossiadis PG, Friberg TR, Panagiotidis DN, Gogas PS, Pantelia EM, Moschos MN. Choroidal neovascularization in primary hyperoxaluria. Am J Ophthalmol. 2002;134(1):134–7.

    Article  PubMed  Google Scholar 

  88. Wells CG, Johnson RJ, Qingli L, Bunt-Millam AH, Kalina E. Retinal oxalosis. A clinicopathologic report. Arch Ophthalmol. 1989;107:1638–43.

    Article  CAS  PubMed  Google Scholar 

  89. Sakamoto T, Maeda K, Sueshi K, Inomata H, Onoyama K. Ocular histopathologic findings in a 46-year-old man with primary hyperoxaluria. Arch Ophthalmol. 1991;109:384–7.

    Article  CAS  PubMed  Google Scholar 

  90. Harrison DA, Mullaney PB, Mesfer SA, Awad AH, Dhindsa H. Management of the ocular complications of homocystinuria. Ophthalmology. 1998;105:1886–90.

    Article  CAS  PubMed  Google Scholar 

  91. Rais L, Wafi M, Lahbil D, Iraki M, Fekkak J, Hamdani M, et al. Ocular and systemic complications of homocystinuria: a report of five cases. [article in French]. J Fr Ophtalmol. 2003;26(10):1045–50.

    CAS  PubMed  Google Scholar 

  92. Muralidhar R, Ankush K, Vijayalakshimi P, George VP. Visual outcome and incidence of glaucoma in patients with microspherophakia. Eye (Lond). 2015;29:350–5.

    Article  CAS  Google Scholar 

  93. Ramsay MS, Yanoff M, Fine BS. The ocular histopathology of homocystinuria. A light and electron microscopic study. Am J Ophthalmol. 1972;74:377–85.

    Article  Google Scholar 

  94. Kim US, Kim JS, Hwang J-M. A case of myotonic dystrophy with pigmentary retinal changes. Korean J Ophthalmol. 2009;23:121–3.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Yamashita T, Matsubara E, Nagano I, Shoji M, Abe K. Bilateral extraocular muscle atrophy in myotonic dystrophy type 1. Neurology. 2004;63(4):759–60.

    Article  CAS  PubMed  Google Scholar 

  96. Sarks J, Liu H, Killingsworth M, Horowitz G, Penfold P, Sarks S. Retinal changes in myotonic dystrophy: a clinicomorphological study. Aust N Z J Ophthalmol. 1985;13:19–36.

    Article  CAS  PubMed  Google Scholar 

  97. Kisilevsky E, Freund P, Margolin E. Mitochondrial disorders and the eye. Surv Ophthalmol. 2020;65:294–311.

    Article  PubMed  Google Scholar 

  98. Saldaña-Martínez A, de Lourdes MM, Pérez-Ramírez G, Montiel-Sosa F, Montoya J, Emperador S, et al. Whole sequenc of the mitochondrial DNA genome of Kearns Sayre syndrome patients: identification of deletions and variants. Gene. 2019;688:171–81.

    Article  PubMed  CAS  Google Scholar 

  99. Padhy SK, Kumar V, Mandal S. Pigmentary retinopathy in Kearns-Sayre syndrome. BMJ Case Rep. 2018;2018:bcr2018227394.

    Article  PubMed Central  Google Scholar 

  100. Phillips CI, Gosden CM. Leber’s hereditary optic neuropathy and Kearns-Sayre syndrome: mitochondrial DNA mutations. Surv Ophthalmol. 1991;35:463–72.

    Article  CAS  PubMed  Google Scholar 

  101. McKechnie NM, King M, Lee WR. Retinal pathology in the Kearns-Sayre syndrome. Br J Ophthalmol. 1985;69:63–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Carta A, D’Adda T, Carrara F, Zeviani M. Ultrastructural analysis of extraocular muscle in chronic progressive external ophthalmoplegia. Arch Ophthalmol. 2000;118:1441–5.

    Article  CAS  PubMed  Google Scholar 

  103. Nesbitt V, Pitceathly RDS, Turnbull DM, Taylor RW, Sweeney MG, Mudanohwo EE, et al. The UK MRC Mitochondrial disease patient cohort study: clinical phenotypes associated with the m.3243A>G mutation—implications for diagnosis and management. J Neurol Neurosurg Psychiatry. 2013;84:936–8.

    Article  PubMed  Google Scholar 

  104. Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, Kakuma T, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820:619–24.

    Article  CAS  PubMed  Google Scholar 

  105. Rummelt V, Folberg R, Ionaescu V, Yi H, Moore KC. Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation. Ophthalmology. 1993;100:1757–66.

    Article  CAS  PubMed  Google Scholar 

  106. Thorburn DR, Rahman J, Rahman S, Adam MP, Ardinger HH, Pagon RA, et al. Mitochondrial DNA-associated Leigh syndrome and NARP. In: Adam MP, Adringer HH, Pagon RA, Wallace SE, Bean LFJ, Stephens K, Amemiya A, editors. GeneReviews. Seattle: University of Washington; 2003. p. 1993–2020.

    Google Scholar 

  107. Hayashi N, Geraghty MT, Green WR. Ocular histopathologic study of a patient with the T 8993-G point mutation in Leigh’s syndrome. Ophthalmology. 2000;107:1397–402.

    Article  CAS  PubMed  Google Scholar 

  108. Kremer I, Lerman Sagie T, Mukamel M, Sandbank M, Nissenkorn I, Mimouni M. Light and electron microscopic findings in Leigh’s disease. Ophthalmologica. 1989;199:106–10.

    Article  CAS  PubMed  Google Scholar 

  109. Ross-Cisneros FN, Pan BX, Silva RA, Miller NR, Albini TA, Tranebjaerg L, et al. Optic nerve histopathology in a case of Wolfram syndrome: a mitochondrial pattern of axonal loss. Mitochondrion. 2013;13:841–5.

    Article  CAS  PubMed  Google Scholar 

  110. Eichhorn-Mulligan K, Cestari DM. The genetics of leber hereditary optic neuropathy-prototype of an inherited optic neuropathy with mitochondrial dysfunction. Semin Ophthalmol. 2008;23:27–37.

    Article  PubMed  Google Scholar 

  111. Jalali H, Najak M, Khoshaeen A, Mahdavi MR, Mahdavi M. First report of c.425-1G>A mutation in ornithine aminotransferase gene causing gyrate atrophy of the choroid and retina with hyperornithemia. Eur J Ophthalmol. 2020;17:1120672120921734. Online ahead of print.

    Google Scholar 

  112. Wilson DJ, Weleber RG, Green WR. Ocular histopathologic study of gyrate atrophy. Am J Ophthalmol. 1991;111:24–33.

    Article  CAS  PubMed  Google Scholar 

  113. Korneld M. Neuropathology of chronic GM2 gangliosidosis due to hexosaminidase a deficiency. Clin Neuropathol. 2008;27:302–8.

    Article  Google Scholar 

  114. Zarrouki M, Yadari ME, Azennoud S, Harchali S, Merrouni SE, Bengarai W, et al. Cherry red spot macula in the context of Tay-Sachs disease. J Fr Ophthalmol. 2017;40:805–6.

    Article  CAS  Google Scholar 

  115. Deibert B, Ferris L, Sanchez N, Weishaar P. The link between colon cancer and congenital hypertrophy of the retinal pigment epithelium (CHRPE). Am J Ophthalmol Case Rep. 2019;15:100524.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Ho DK, Levin AV, Anninger WV, Piccoli DA, Eagle RC Jr. Anterior chamber pathology in Alagille syndrome. Ocul Oncol Pathol. 2016;2:20–275.

    Article  Google Scholar 

  117. Hingorani M, Nischal KK, Davies A, Bentley C, Vivian A, Baker AJ, et al. Ocular abnormalities in Alagille syndrome. Ophthalmology. 1999;106:330–7.

    Article  CAS  PubMed  Google Scholar 

  118. Altschwager P, Ambrosio L, Swanson EA, Moskowitz A, Fulton AB. Juvenile macular degnerations. Semin Pediatr Neurol. 2017;24:104–9.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Souied E, Kaplan J, Coscas G, Soubrane G. Macular dystrophies. J Fr Ophtalmol. 2003;26:743–62.

    CAS  PubMed  Google Scholar 

  120. Tripathy K, Salni B. Best disease. In: Stat Pearls [Internet]. Treasure Island, FL: StatPearls; 2020.

    Google Scholar 

  121. Chowers I, Tiosano L, Audo I, Grunin M, Boon CJF. Adult-onset foveomacular vitelliform dystrophy: a fresh perspective. Prog Retin Eye Res. 2015;47:64–85.

    Article  CAS  PubMed  Google Scholar 

  122. Frangieh GT, Green WR, Fine SL. A histopathologic study of Best’s macular dystrophy. Arch Ophthalmol. 1982;100:1115–21.

    Article  CAS  PubMed  Google Scholar 

  123. Weingeist TA, Kobrin JL, Watzke RC. Histopathology of Best’s macular dystrophy. Arch Ophthalmol. 1982;100:1108–14.

    Article  CAS  PubMed  Google Scholar 

  124. O’Gorman S, Flaherty WA, Fisman GA, Berson EL. Histopathologic findings in Best’s vitelliform macular dystrophy. Arch Ophthalmol. 1988;106:1261–8.

    Article  PubMed  Google Scholar 

  125. Zhang Q, Small KW, Grossniklaus HE. Clinicopathologic findings in best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2011;249:745–51.

    Article  PubMed  Google Scholar 

  126. Tsang SH, Sharma T. Stargardt disease. In: Tsang S, Sharma T, editors. Atlas of inherited retinal diseases. Advances in experimental medicine and biology, vol. 1085; 2018. p. 139–51.

    Chapter  Google Scholar 

  127. Cremers FPM, Lee W, Collin RWJ, Allikmets R. Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations. Prog Retin Eye Res. 2020;9:100861.

    Article  CAS  Google Scholar 

  128. Rahman N, Georgiou M, Khan KN, Michaelides M. Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options. Br J Ophthalmol. 2020;104:451–60.

    Article  PubMed  Google Scholar 

  129. Eagle RC, Lucier AC, Bernardino VB, Yanoff M. Retinal pigment epithelial abnormalities in fundus flavimaculatus. Ophthalmology. 1980;87:1189–200.

    Article  PubMed  Google Scholar 

  130. Steinmetz RL, Garner A, Maguire JI, Bird AC. Histopathology of incipient fundus flavimaculatus. Ophthalmology. 1991;98:953–9561.

    Article  CAS  PubMed  Google Scholar 

  131. Birnbach CD, Jarvelainen M, Possin DE, Milam AH. Histopathological and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology. 1994;101:1211–9.

    Article  CAS  PubMed  Google Scholar 

  132. Horgan HC, McFadzean RM, Lee WR. Idiopathic intracranial hypertension. J Neuroophthalmol. 1998;19:182–5.

    Google Scholar 

  133. Gu XZ, Tsai JC, Wurdeman A, Wall M, Foote T, Sadun AA. Pattern of axonal loss in longstanding papilledema due to idiopathic intracranial hypertension. Curr Eye Res. 1995;14(3):173–80.

    Article  CAS  PubMed  Google Scholar 

  134. Birch MK, Barbosa S, Blumhardt LD, O’Brien C, Harding SP. Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis. Arch Ophthalmol. 1996;114:34–9.

    Article  CAS  PubMed  Google Scholar 

  135. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis:retinal atrophy and inflammation irrespective of disease duration. Brain. 2010;133:1591–601.

    Article  PubMed  PubMed Central  Google Scholar 

  136. Ucciferro P, Anastasopoulou C. Empty sella. In: StatsPearls [Internet]. Treasure Island, FL: StatPearls; 2020.

    Google Scholar 

  137. Kordyś M, Przeździecka-Dolyk J, Turno-Kręcicka A, Misiuk-Hojlo M. Imunopathogenesis of ophthalmological paraneoplastic syndroes: recent findings. Adv Clin Exp Med. 2018;27:1431–9.

    Article  PubMed  Google Scholar 

  138. Adamus G, Webb S, SHiraga S, Duvoisin RM. Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. J Autoimmun. 2006;26:146–53.

    Article  CAS  PubMed  Google Scholar 

  139. Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, Adamus G. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolse antibodies. Am J Ophthalmol. 2005;139:780–94.

    Article  CAS  PubMed  Google Scholar 

  140. Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol. 2013;5:430–58.

    Article  Google Scholar 

  141. Suimon Y, Saito W, Hirooka K, Kanda A, Kitai H, Sakakibara-Konishi J, Ishida S. Improvements of visual function and outer retinal morphology following spontaneous regression of cancer in anti-recoverin cancer-associated retinopathy. Am J Ophthalmol Case Rep. 2017;5:137–40.

    Article  PubMed  PubMed Central  Google Scholar 

  142. Cohen DA, Bhatti MT, Pulido JS, Lennon AV, Dubey D, Flanag EP, et al. Collapsin response-mediator protein 5-associated retinitis, vitritis, and optic disc edema. Ophthalmology. 2020;127:221–9.

    Article  PubMed  Google Scholar 

  143. Cross SA, Salomao DR, Parisi JE, Kryzer TJ, Bradley EA, Mines JA, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol. 2003;54:38–50.

    Article  PubMed  Google Scholar 

  144. Schmid KE, Kornek GV, Scheithaeuer W, Binder S. Update on ocular complications of systemic cancer chemotherapy. Surv Ophthalmol. 2006;51:19–40.

    Article  PubMed  Google Scholar 

  145. Renouf DJ, Velazquez-Martin JP, Simpson R, Siu LL, Bedard PL. Ocular toxicity of targeted therapies. J Clin Oncol. 2012;30:3277–86.

    Article  CAS  PubMed  Google Scholar 

  146. Barrett TG, Bundey SE, Fielder AR, Good PA. Optic atrophy in Wolfram (DIDMOAD) syndrome. Eye. 1997;11:882–8.

    Article  PubMed  Google Scholar 

  147. Freeman AG. Optic neuropathy and chronic cyanide intoxication. J R Soc Med. 1988;81:103–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  148. Smiddy WE, Green WR. Nutritional amblyopia. A histopathologic study with retrospective clinical correlation. Graefes Arch Clin Exp Ophthalmol. 1987;225:321–4.

    Article  CAS  PubMed  Google Scholar 

  149. Carden SM, Boissy RE, Schoettker PJ, Good WV. Albinism: modern molecular diagnosis. Br J Ophthalmol. 1998;82:189–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  150. Akeo K, Shirai S, Okisaka S, Shimizu H, Miyata H, Kikuchi A, et al. Histology of fetal eyes with oculocutaneous albinism. Arch Ophthalmol. 1996;114:613–6.

    Article  CAS  PubMed  Google Scholar 

  151. Mietz H, Green WR, Wolff SM, Abundo GP. Foveal hypoplasia in complete oculocutaneous albinism. Retina. 1992;12:254–60.

    Article  CAS  PubMed  Google Scholar 

  152. Suzuki T, Ohga H, Katayama T, Egi K, Fujiwara H, Mizushima M. A girl with Hermansky-Pudlak syndrome. Acta Ophthalmol. 1991;69:256–60.

    Article  CAS  Google Scholar 

  153. Kumar A, Agarwal S. Marfan syndrome: an eyesight of syndrome. Meta Gene. 2014;2:96–105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  154. Scroggs MW, Klintworth GK. Drugs and toxins. In: Garner A, Klintworth GK, editors. Pathobiology of ocular disease. New York: Marcel Dekker; 1994. p. 1163–88.

    Google Scholar 

  155. Dhingra D, Kaur S, Ram J. Illicit drugs: effects on eye. Indian J Med Res. 2019;150:228–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  156. Kim H-A, Lee S, Eah KS, Yoon YH. Prevalence and risk factors of tamoxifen retinopathy. Ophthalmology. 2020;127:555–7.

    Article  PubMed  Google Scholar 

  157. Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology. 2003;110:1321–6.

    Article  PubMed  Google Scholar 

  158. Richa S, Yazbek J-C. Ocular adverse effects of common psychotropic agents: a review. CNS Drugs. 2010;24:501–26.

    Article  CAS  PubMed  Google Scholar 

  159. Novak MA, Roth AS, Levine MR. Calcium oxalate retinopathy associated with methoxyflurane abuse. Retina. 1988;8:230–6.

    Article  CAS  PubMed  Google Scholar 

  160. Nazarian SM, Jay WM. Bilateral optic neuropathy association with amiodarone therapy. J Clin Neuroopthalmol. 1988;8:25–8.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK

    Fiona Roberts

  2. Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, UK

    Chee Koon Thum

Authors
  1. Fiona Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chee Koon Thum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fiona Roberts .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Roberts, F., Thum, C.K. (2021). “Autopsy Eye”: The Eye in Systemic Disease. In: Lee's Ophthalmic Histopathology. Springer, Cham. https://doi.org/10.1007/978-3-030-76525-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-76525-5_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-76524-8

  • Online ISBN: 978-3-030-76525-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation